SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the availability of its BioXp® Select ...

SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® ...

SAN DIEGO--(BUSINESS WIRE)--SGI-DNA announces the launch of the Multi-Tile Assembly Cloning (MTAC) application for its BioXp™ 3200 System, providing scientists with the ability to synthesize two genes ...

SGI-DNA Inc. today announced the launch of the BioXp™ 3200 System Early Access Program giving researchers priority access to this one of a kind, personal DNA work station which delivers high quality ...

The BioXp ™ 3200 system is an automated personal genomic workstation that builds and clones DNA fragments in a process that is virtually hands-free. In an overnight run, the instrument generates ...

SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its ...

Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility ...

Advancing Craig Venter’s vision of digitizing life, a company founded by the genome pioneer has started early sales of a new DNA workstation that assembles high-quality DNA sequences almost from ...

Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, has announced the availability of its BioXp® Select mRNA Synthesis Kit. This kit enables on-demand and automated ...